688185.SH
康希诺
SSE · Healthcare · Biotechnology · CN
CNY 75.50
−2.35%Margins
Gross margin
77.5%
EBITDA margin
17.4%
EBIT margin
0.5%
Net margin
-0.1%
FCF margin
-15.2%
-0.0%
Return on equity
-0.0%
Return on assets
0.1%
Return on invested capital
0.16x
Asset turnover
CNY 37.8M
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026